Eye health company Bausch + Lomb has officially launched the Arise orthokeratology lens system in the US for myopia correction.
The system employs intelligent, cloud-based technology to enhance the design process for orthokeratology lenses, which correct myopia by reshaping the cornea overnight.
Arise connects directly with topographers to generate precise lens designs in mere seconds. This new product features a US Food and Drug Administration (FDA)-approved orthokeratology lens design incorporating toric peripheral curves for overnight myopia correction.
Myopia, commonly known as nearsightedness, is a prevalent eye condition and a significant cause of visual impairment among children globally.
The Arise system is engineered to interpret corneal images rapidly using advanced algorithms, offering lens recommendations without the need for a fitting set. It caters to lens fitters across all experience levels and evaluates lens centring and patient outcomes using an overnight map library, advising on adjustments as needed.
Its cloud-based nature allows for secure access to patient data and direct consultation with Bausch + Lomb experts from any location.
Bausch + Lomb global vision care president Yang Yang said: “Traditional orthokeratology lens fitting methods can be complex and time-consuming.
“The Arise platform’s streamlined fitting process will reduce chair time and increase efficiency for eye care professionals.”
Arise is now available not only in the US. but also in the UK and Europe.
The Boston Orthokeratology lenses, designed for overnight use, aim to reduce myopic refractive error in healthy eyes. They are part of Bausch + Lomb’s Vision Shaping Treatment (VST) process to temporarily reduce myopia by up to 5.00 diopters, accommodating astigmatism up to 1.50 diopters.
According to Bausch + Lomb, the lenses require chemical disinfection.
